Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome

This publication has 20 references indexed in Scilit:

• Thromboprophylaxis in Antiphospholipid Syndrome Pregnancies with Previous Cerebral Arterial Thrombotic Events: Is Warfarin Preferable?
  Thrombosis and Haemostasis, 1998
• Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
  BMJ, 1997
• Antiphospholipid antibody–associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
  American Journal of Obstetrics and Gynecology, 1996
• Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy
  American Journal of Obstetrics and Gynecology, 1995
• The Immunobiology and Obstetrical Consequences of Antiphospholipid Antibodies
  Obstetrical & Gynecological Survey, 1994
• Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients
  The American Journal of Medicine, 1994
• The antiphospholipid syndrome: ten years on
  The Lancet, 1993
• Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment
  American Journal of Obstetrics and Gynecology, 1992
• Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody
  American Journal of Obstetrics and Gynecology, 1989
• Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant
  American Journal of Obstetrics and Gynecology, 1982